05-18-2020, 07:46 AM
** 18-May-2020 World View: Stock futures surge on Moderna vaccine news
Stock futures are soaring this morning on the news that a vaccine
developed by drug maker Moderna has seen positive results in a phase I
trial. Only eight participants were involved in the phase I trial,
but the results were far better than results from phase 1 trials
conducted by other companies so far.
Moderna started working on its Covid-19 vaccine as soon as Chinese
scientists put out the gene sequence for the virus in January. By late
February, Moderna’s scientists had already delivered the first batch
of candidate vaccines to researchers at the U.S. National Institutes
of Health. In mid-March, the first healthy patient received a dose in
the government-sponsored safety trial. (Bloomberg)
A phase 2 trial will begin right away, and a phase 3 trial is
scheduled for July.
The Trump administration "Warp Speed" policy is for the federal
government to fund manufacturing millions of doses of a test vaccine,
even while testing is underway, so that the vaccine can be deployed as
quickly as possible, by the end of this year.
There's also an international political furor developing over how any
successful vaccine will be distributed -- and whether it will be
available to developing countries as well as to Western countries.
There's also a suspicion that if China is the first to develop a
vaccine, then they will be unwilling to share it.
The preliminary results with 8 people have been very encouraging,
based on new technology developed by Moderna. Stock futures are
surging this morning, but as we all know, they'll fall just as quickly
if anything goes wrong with the tests.
---- Sources:
-- Early data show Moderna Covid-19 vaccine generates immune response
https://www.statnews.com/2020/05/18/earl...-response/
(Stat News, 18-May-2020)
-- Coronavirus Vaccine From Moderna Shows Early Signs of Viral Immune
Response
https://www.bloomberg.com/news/articles/...e-response
(Bloomberg, 18-May-2020)
Stock futures are soaring this morning on the news that a vaccine
developed by drug maker Moderna has seen positive results in a phase I
trial. Only eight participants were involved in the phase I trial,
but the results were far better than results from phase 1 trials
conducted by other companies so far.
Moderna started working on its Covid-19 vaccine as soon as Chinese
scientists put out the gene sequence for the virus in January. By late
February, Moderna’s scientists had already delivered the first batch
of candidate vaccines to researchers at the U.S. National Institutes
of Health. In mid-March, the first healthy patient received a dose in
the government-sponsored safety trial. (Bloomberg)
A phase 2 trial will begin right away, and a phase 3 trial is
scheduled for July.
The Trump administration "Warp Speed" policy is for the federal
government to fund manufacturing millions of doses of a test vaccine,
even while testing is underway, so that the vaccine can be deployed as
quickly as possible, by the end of this year.
There's also an international political furor developing over how any
successful vaccine will be distributed -- and whether it will be
available to developing countries as well as to Western countries.
There's also a suspicion that if China is the first to develop a
vaccine, then they will be unwilling to share it.
The preliminary results with 8 people have been very encouraging,
based on new technology developed by Moderna. Stock futures are
surging this morning, but as we all know, they'll fall just as quickly
if anything goes wrong with the tests.
---- Sources:
-- Early data show Moderna Covid-19 vaccine generates immune response
https://www.statnews.com/2020/05/18/earl...-response/
(Stat News, 18-May-2020)
-- Coronavirus Vaccine From Moderna Shows Early Signs of Viral Immune
Response
https://www.bloomberg.com/news/articles/...e-response
(Bloomberg, 18-May-2020)
